Figure 3.
THZ1 perturbs the cellular metabolic pathways of B-ALL cells. (A,B) Principal component analysis and correlation analysis of the RNA-SEQ data in THZ1- and DMSO-treated NALM6 cells. (C,D) Volcano plot and heatmap of differentially expressed genes by a log2-fold change ≥ 1.5 or ≤ −1.5 (p < 0.05) in THZ1- and DMSO-treated NALM6 cells. (E) Pathway analysis of upregulated and downregulated genes (p < 0.05) in THZ1- and DMSO-treated NALM6 cells. (F) KEGG pathway analysis of downregulated metabolic genes (p < 0.05) in THZ1- and DMSO-treated NALM6 cells. (G) KEGG pathway analysis of downregulated metabolic genes (p < 0.05) in THZ1- and DMSO-treated NALM6 cells. (H) Gene set enrichment analysis of the genes related to glucose, amino acid, and nucleotide metabolism. B-ALL cells were treated with THZ1 for 24 h.